Skip to content
Sign in

OFIX · NASDAQ

Orthofix Medical (OFIX) Stock Price & Fundamentals

$779.87−0.54%−$4.23End-of-day price as of Oct 9, 2026

Orthofix Medical (OFIX) closed at $779.87 on Oct 9, 2026, down 0.54% from the previous close of $784.10.

Share price, past year

1Y +1.61%

52-week range $750.62 – $883.28. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$779.87
Sep 30, 2026$788.06
Aug 31, 2026$750.62
Jul 31, 2026$775.39
Jun 30, 2026$803.73
May 29, 2026$804.31
Apr 30, 2026$836.17
Mar 31, 2026$855.21
Feb 27, 2026$850.29
Jan 30, 2026$816.67
Dec 31, 2025$806.94
Nov 28, 2025$782.68
Oct 31, 2025$771.09

Key statistics

Market cap
$31.76B
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
$833.19M
Net income (TTM)
−$61.72M
Shares outstanding
40.7M
Dividend yield
—
52-week range
$750.62 – $883.28

Orthofix Medical's market cap is $31.76B, based on a share price of $779.87 and 40.7M shares outstanding as of Jun 30, 2026.

Financials

Orthofix Medical reported revenue of $822.31M for fiscal 2025, up 2.85% from fiscal 2024.

Orthofix Medical reported a net loss of $92.19M in fiscal 2025.

Fiscal 2025 revenue was the highest in the 10 years shown.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
Orthofix Medical annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$822.31M+2.9%−$92.19M−11.2%−$2.33—
FY2024ended Dec 31, 2024$799.49M+7.1%−$126.00M−15.8%−$3.30—
FY2023ended Dec 31, 2023$746.64M+62.1%−$151.40M−20.3%−$4.12−$106.01M
FY2022ended Dec 31, 2022$460.71M−0.8%−$19.75M−4.3%−$0.98−$32.90M
FY2021ended Dec 31, 2021$464.48M+14.3%−$38.38M−8.3%−$1.95$690.00K
FY2020ended Dec 31, 2020$406.56M−11.6%$2.52M0.6%$0.13$58.79M
FY2019ended Dec 31, 2019$459.96M+1.5%−$28.46M−6.2%−$1.51$13.04M
FY2018ended Dec 31, 2018$453.04M+4.4%$13.81M3.1%$0.72$36.33M
FY2017ended Dec 31, 2017$433.82M+5.9%$6.22M1.4%$0.34$24.31M
FY2016ended Dec 31, 2016$409.79M—$3.06M0.8%$0.17$42.64M
Orthofix Medical quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$210.93M−$15.80M−$0.39
Q1 FY2026ended Mar 31, 2026$196.71M−$20.91M−$0.52
Q4 FY2025ended Dec 31, 2025$219.91M−$2.22M—
Q3 FY2025ended Sep 30, 2025$205.63M−$22.80M−$0.57
Q2 FY2025ended Jun 30, 2025$203.12M−$14.08M−$0.36
Q1 FY2025ended Mar 31, 2025$193.65M−$53.09M−$1.35
Q4 FY2024ended Dec 31, 2024$215.66M−$29.15M—
Q3 FY2024ended Sep 30, 2024$196.61M−$27.39M−$0.71

Company profile

Name
Orthofix Medical Inc.
Ticker
OFIX
Exchange
NASDAQ
Industry (SEC SIC)
Surgical & Medical Instruments & Apparatus
Headquarters
3451 Plano Parkway, Lewisville, TX 75056
Fiscal year ends
December
SEC CIK
0000884624

Recent SEC filings

Frequently asked questions

What is Orthofix Medical's stock price?

Orthofix Medical (OFIX) closed at $779.87 on Oct 9, 2026, down 0.54% from the previous close of $784.10.

What is Orthofix Medical's market cap?

Orthofix Medical's market cap is $31.76B, based on a share price of $779.87 and 40.7M shares outstanding as of Jun 30, 2026.

How much revenue does Orthofix Medical make?

Orthofix Medical reported revenue of $822.31M for fiscal 2025, up 2.85% from fiscal 2024.

Does Orthofix Medical pay a dividend?

Orthofix Medical's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from Orthofix Medical Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures